Bailard, Inc. Cidara Therapeutics, Inc. Transaction History

Bailard, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 16, 2020	SELL	$1.74 - $4.26 $51,055 - $124,996	-29,342 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$1.77 - $3.84 $27,155 - $58,913	15,342 Added 109.59%	29,342 $113,000
Q4 2015 Jan 29, 2018	BUY	N/A	14,000	14,000 $0

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.33B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.